If you or a loved one was taking 10 mg of Xeljanz twice a day and suffered a pulmonary embolism, stroke, deep vein thrombosis, or another type of blood clot-induced injury, you may have a valid claim for damages against Pfizer.
Find out if you’re eligible to file a Xeljanz lawsuit by speaking with the team at Bart Bernard Injury Lawyers. There are strict deadlines for taking legal action in a product liability case. Call or email today to discuss the merits of your claim, so you can make an informed decision. The consultation is offered free of charge and is an easy way to protect your interests after a serious drug-related injury or loss of a loved one.
Xeljanz complications and side effects
Tofacitinib works by suppressing the immune system and is associated with a number of adverse side effects that are displayed on the product label.
Common Xeljanz side effects include:
- Diarrhea
- Cellulitis
- Throat irritation, stuffy nose, and cold symptoms
- Headaches
- Increased blood pressure
- Shingles or skin rash
Less common reactions to the drug:
- Serious bacterial infections
- Non-melanoma skin cancers
- Angioedema
- Increased liver enzymes
- Systemic fungal infections
- Perforations of the stomach or intestines
- Blood clots in the arteries or lungs
- Pneumonia
- Malignant Lymphoma
- Squamous Cell Carcinoma
Due to the life-threatening nature of blood clots, the FDA encourages health care professionals to stop Xeljanz in patients who show symptoms of thrombosis (blood clots). Patients who are experiencing signs of a Xeljanz pulmonary embolism must seek medical attention immediately. Shortness of breath, unusual sweating, and severe chest pain may be early indicators.
Xeljanz FDA warning
In July of 2019, the FDA issued a new warning about an increased risk of pulmonary embolism and death in those taking 10 mg of Xeljanz and Xeljanz XR twice daily. This dosage is commonly prescribed to patients suffering from ulcerative colitis. Symptoms of blood clots include sudden difficulty breathing, leg pain or tenderness, swelling of an arm or leg, or chest pain that becomes worse with breathing. The boxed warning is based on the interim results of a clinical trial that found a higher rate of blood clots in the lungs and death in patients treated with 10 mg of Xeljanz twice daily compared to those taking an alternative drug or lower doses.
Xeljanz complaints against Pfizer
There are many allegations that plaintiffs may level in a Xeljanz lawsuit claim. Pfizer may have to defend complaints that the company:
- Failed to conduct sufficient pre-market trials to establish the safety of Xeljanz and Xeljanz XR
- Negligently failed to disclose that higher doses of the drug can induce life-threatening blood clots and other side effects
- Manufactured, marketed and sold a drug that is unreasonably dangerous for its intended purpose
Given the recent FDA warning about Xeljanz pulmonary embolism risk and deaths, Pfizer may be named in dozens of lawsuits across the nation in the coming months.
Why you need an experienced defective drug lawyer
Suing pharmaceutical giants for drug-related injuries is no easy task. When pursuing money damages in a Xeljanz lawsuit, you need an attorney who comprehends product liability law — someone who can fight for the compensation you deserve for lost income, medical bills, and the emotional suffering your family has endured. Bart Bernard is The People’s Trial Lawyer™. He has the resources and knowledge to achieve the best outcome in your case, whether you developed deep vein thrombosis, liver problems, or another Xeljanz side effect. Drug manufacturers who fail to warn about potential adverse outcomes, or who market a dangerous and defective product may be held liable in a court of law.
Protect yourself and those you love by reaching out to Bart Bernard Injury Lawyers. We have decades of experience handling drug injury litigation on both the state and federal level. Our firm is currently investigating cases involving all types of health complaints and injuries related to Xeljanz exposure.
Hit Hard. Get Bart Bernard.™
If you or a loved one developed a pulmonary embolism or another injury after taking tofacitinib, contact Bart Bernard Injury Lawyers for more information about legal remedies available in your situation. The initial Xeljanz case review is complimentary and there is no obligation to retain our services.
Bart Bernard and his legal team are well-versed in national litigation involving defective drugs and boast a long track record of successful verdicts and settlements. Discuss your options with a qualified Xeljanz lawyer before the statute of limitations runs out. Our firm offers exceptional, client-focused representation on a contingency fee basis, which means we don’t get paid unless you recover compensation.
Additional Resources:
- Medical News Today, Xeljanz (tofacitinib) https://www.medicalnewstoday.com/articles/326446.php
- Medscape, FDA Adds Boxed Warning on Risk for PE, Death With Higher Dose Tofacitinib (Xeljanz) https://www.medscape.com/viewarticle/916105
- FDA, FDA approves Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR) https://www.fda.gov/drugs/drug-safety-and-availability/fda-approves-boxed-warning-about-increased-risk-blood-clots-and-death-higher-dose-arthritis-and
- National Law Review, What Is the Deal With Xeljanz Lawsuits? https://www.natlawreview.com/article/what-deal-xeljanz-lawsuits
